Notal Vision is a pioneering brand that aims to improve vision outcomes by extending eye disease management from the clinic to the home. They utilize artificial intelligence (AI)-driven data interpretation to analyze the unprecedented volumes of data generated by patients at home, advancing eye care through precision medicine. Their flagship product, ForeseeHome, is an early warning system that helps physicians diagnose wet AMD earlier, leading to better long-term visual outcomes.

They also offer Notal Home OCT, a home monitoring system for wet AMD treatment that allows personalized medicine and treatment between office visits. Headquartered in Manassas, Virginia, Notal Vision has its roots in Tel Aviv's innovative culture. Their leadership team combines years of expertise in ophthalmology, product development, clinical development, and commercialization.

The brand's Monitoring Center provides continual access to data, enabling timely reports to patients and their physicians when there are significant changes in testing results. Notal Vision's future pipeline includes home-based Optical Coherence Tomography (OCT), which will revolutionize individualized, continuous assessments of each patient's disease status and enable personalized medicine. With a commitment to patient-centered care and industry-leading innovation, Notal Vision is revolutionizing eye disease management